Clinical Trial Update: Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chlorambucil versus fludarabine as first-line therapy for previously untreated Waldenström macroglobulinemia, splenic lymphoma, or ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoplasmacytic Lymphoma
• Splenic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• Chlorambucil (chlorambucil)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Taunton and Somerset Hospital | Conditions: Lymphoma | Phase 3 | Status: COMPLETED